Aging
Navigate
Editorial|Volume 11, Issue 23|pp 10791—10792

PCSK9 inhibition in high-risk patients

Laurien E. Zijlstra1, Simon P. Mooijaart2,3, J. Wouter Jukema1
  • 1Department of Cardiology Leiden University Medical Center, The Netherlands
  • 2Department of Gerontology and Geriatrics Leiden University Medical Center, The Netherlands
  • 3Institute for Evidence-based Medicine in Old Age (IEMO), Leiden, the Netherlands
Received: October 31, 2019Accepted: December 5, 2019Published: December 11, 2019

Copyright © 2019 Zijlstra et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.